Literature DB >> 24916315

Human osteoclasts are inducible immunosuppressive cells in response to T cell-derived IFN-γ and CD40 ligand in vitro.

Haiyan Li1, Yong Lu, Jianfei Qian, Yuhuan Zheng, Mingjun Zhang, Enguang Bi, Jin He, Zhiqiang Liu, Jingda Xu, Jerry Y Gao, Qing Yi.   

Abstract

Osteoclasts (OCs) are bone resorbing cells whose activity can be regulated by activated T cells and their cytokines. However, the immune function of OCs is largely unknown. In this study, we found that as bystanders, human OCs effectively suppressed T-cell proliferation induced by allogeneic, microbial antigenic, and T-cell receptor stimuli in vitro. Mechanism studies revealed that T cell-derived IFN-γ and CD40 ligand (CD40L) induced the expression of indoleamine 2,3-dioxygenase (IDO) in OCs, which mediated the immunosuppressive function on T-cell proliferation through depleting tryptophan. Neutralizing IFN-γ and blocking CD40L, or silencing or inhibiting IDO in OCs restored T-cell proliferation in the presence of OCs. Our data reveal a novel function of human OCs as inducible immunosuppressive cells, and a feedback loop between OCs and activated T cells. Thus, this study provides new insight into the mechanism of the immunosuppressive function of OCs, and may be helpful for developing novel therapeutic strategies for human diseases involving both the bone and immune systems.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  CD40L; IDO; IFN-γ; OSTEOCLASTS; OSTEOIMMUNOLOGY; T CELLS

Mesh:

Substances:

Year:  2014        PMID: 24916315      PMCID: PMC4262718          DOI: 10.1002/jbmr.2294

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  40 in total

1.  Bone versus immune system.

Authors:  J R Arron; Y Choi
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

Review 2.  CD40 and dendritic cell function.

Authors:  Brendan O'Sullivan; Ranjeny Thomas
Journal:  Crit Rev Immunol       Date:  2003       Impact factor: 2.214

3.  Bone marrow as a priming site for T-cell responses to blood-borne antigen.

Authors:  Markus Feuerer; Philipp Beckhove; Natalio Garbi; Yolanda Mahnke; Andreas Limmer; Mirja Hommel; Günter J Hämmerling; Bruno Kyewski; Alf Hamann; Viktor Umansky; Volker Schirrmacher
Journal:  Nat Med       Date:  2003-08-10       Impact factor: 53.440

Review 4.  The bone marrow: a nest for migratory memory T cells.

Authors:  Francesca Di Rosa; Reinhard Pabst
Journal:  Trends Immunol       Date:  2005-07       Impact factor: 16.687

Review 5.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

6.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

7.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.

Authors:  H Takayanagi; K Ogasawara; S Hida; T Chiba; S Murata; K Sato; A Takaoka; T Yokochi; H Oda; K Tanaka; K Nakamura; T Taniguchi
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

8.  Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.

Authors:  B Berner; D Akça; T Jung; G A Muller; M A Reuss-Borst
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

9.  Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

Authors:  S R Bennett; F R Carbone; F Karamalis; R A Flavell; J F Miller; W R Heath
Journal:  Nature       Date:  1998-06-04       Impact factor: 49.962

10.  Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.

Authors:  Anandi Sawant; Jessy Deshane; Joel Jules; Carnella M Lee; Brittney A Harris; Xu Feng; Selvarangan Ponnazhagan
Journal:  Cancer Res       Date:  2012-12-14       Impact factor: 12.701

View more
  13 in total

1.  Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.

Authors:  Gang An; Chirag Acharya; Xiaoyan Feng; Kenneth Wen; Mike Zhong; Li Zhang; Nikhil C Munshi; Lugui Qiu; Yu-Tzu Tai; Kenneth C Anderson
Journal:  Blood       Date:  2016-07-14       Impact factor: 22.113

Review 2.  Osteoimmunology: from mice to humans.

Authors:  Patrizia D'Amelio; Francesca Sassi
Journal:  Bonekey Rep       Date:  2016-05-18

3.  E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.

Authors:  Enguang Bi; Rong Li; Laura C Bover; Haiyan Li; Pan Su; Xingzhe Ma; Chunjian Huang; Qiang Wang; Lintao Liu; Maojie Yang; Zhijuan Lin; Jianfei Qian; Weijun Fu; Yong-Jun Liu; Qing Yi
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

Review 4.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

Review 5.  Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis.

Authors:  Johann Lechner; Tatjana Rudi; Volker von Baehr
Journal:  Clin Cosmet Investig Dent       Date:  2018-11-09

Review 6.  Chronic Implant-Related Bone Infections-Can Immune Modulation be a Therapeutic Strategy?

Authors:  Elisabeth Seebach; Katharina F Kubatzky
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

7.  Lithium chloride with immunomodulatory function for regulating titanium nanoparticle-stimulated inflammatory response and accelerating osteogenesis through suppression of MAPK signaling pathway.

Authors:  Chao Yang; Wei Wang; Kechao Zhu; Wei Liu; Yao Luo; Xiangwei Yuan; Jiaxing Wang; Tao Cheng; Xianlong Zhang
Journal:  Int J Nanomedicine       Date:  2019-09-12

8.  Harmine Alleviates Titanium Particle-Induced Inflammatory Bone Destruction by Immunomodulatory Effect on the Macrophage Polarization and Subsequent Osteogenic Differentiation.

Authors:  Liangliang Wang; Qing Wang; Wei Wang; Gaoran Ge; Nanwei Xu; Dong Zheng; Shijie Jiang; Gongyin Zhao; Yaozeng Xu; Yuji Wang; Ruixia Zhu; Dechun Geng
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 9.  Osteoimmunology and Beyond.

Authors:  Lia Ginaldi; Massimo De Martinis
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

10.  Evaluation of Tryptophan/Kynurenine Pathway Relevance With Immune System Biomarkers of Low Energy Trauma Hip Fractures in Osteoporotic Patients.

Authors:  Ercan Dinçel; Yeşim Özkan; Murat Şüküroğlu; Hakan Özsoy; Aylin Sepici Dinçel
Journal:  Arch Rheumatol       Date:  2017-03-24       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.